F-group (family)
7510.1.1.1 Iso_dh
Ligands and drugs
2,479
Member domains
881
with ligand contacts (≤ 4 Å)
35.5% of members
822
with DrugDomain annotations
33.2% of members
651
with a DrugBank compound
26.3% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 7510.1.1.1 belongs to X-group 7510 Isocitrate/Isopropylmalate dehydrogenase-like, which binds 7.6 ligand superclasses per 20 proteins, narrower than 51% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03461 | NAP | Nicotinamide adenine dinucleotide phosphate | 163 |
| DB02338 | NDP | NADPH | 119 |
| DB08845 | AKG | Oxogluric acid | 92 |
| DB14128 | NAD | Nadide | 83 |
| DB04279 | IPM | 3-Isopropylmalic Acid | 61 |
| DB00157 | NAI | NADH | 30 |
| DB00131 | AMP | Adenosine phosphate | 19 |
| DB16833 | ADP | Adenosine disphosphate | 12 |
| DB17097 | 9UO | Vorasidenib | 9 |
| DB18745 | 7SU | Safusidenib | 8 |
| DB00171 | ATP | ATP | 6 |
| DB03434 | MPO | 3-(N-morpholino)propanesulfonic acid | 6 |
| DB03709 | BCN | Bicine | 5 |
| DB01727 | — | Isocitric Acid | 4 |
| DB04349 | PGO | (S)-propane-1,2-diol | 4 |
| DB06757 | — | — | 4 |
| DB16267 | PWV | Olutasidenib | 4 |
| DB04447 | DTT | 1,4-Dithiothreitol | 3 |
| DB01763 | TAP | 7-thionicotinamide-adenine-dinucleotide phosphate | 2 |
| DB02098 | A2P | Adenosine-2'-5'-Diphosphate | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAP | NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE | 174 |
| ICT | ISOCITRIC ACID | 156 |
| MGmetal | MAGNESIUM ION | 127 |
| CAmetal | CALCIUM ION | 116 |
| NDP | NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE | 111 |
| AKG | 2-OXOGLUTARIC ACID | 100 |
| NAD | NICOTINAMIDE-ADENINE-DINUCLEOTIDE | 80 |
| IPM | 3-ISOPROPYLMALIC ACID | 64 |
| CL | CHLORIDE ION | 36 |
| NAI | 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE | 28 |
| MNmetal | MANGANESE (II) ION | 26 |
| AMP | ADENOSINE MONOPHOSPHATE | 16 |
| EE1 | (3~{S})-3-[(4~{S})-3-aminocarbonyl-1-[(2~{R},3~{R},4~{S},5~{R})-5-[[[[(2~{R},3~{R},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3-oxidanyl-4-phosphonooxy-oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxymethyl]-3,4-bis(oxidanyl)oxolan-2-yl]-4~{H}-pyridin-4-yl]-2-oxidanylidene-pentanedioic acid | 14 |
| SCN | THIOCYANATE ION | 12 |
| ZT3 | N-(4-tert-butylphenyl)-7,8-dimethyl-5,11-dihydro-6H-pyrido[2,3-b][1,5]benzodiazepine-6-carboxamide | 12 |
| 48Y | (1R,2S)-1-hydroxybutane-1,2,4-tricarboxylic acid | 10 |
| NAmetal | SODIUM ION | 10 |
| 9UO | 6-(6-chloropyridin-2-yl)-N2,N4-bis[(2R)-1,1,1-trifluoropropan-2-yl]-1,3,5-triazine-2,4-diamine | 9 |
| LMR | (2S)-2-hydroxybutanedioic acid | 9 |
| 70P | (4S)-3-(2-{[(1S)-1-phenylethyl]amino}pyrimidin-4-yl)-4-(propan-2-yl)-1,3-oxazolidin-2-one | 8 |